
Sumitomo Pharma Hits Day Low of JPY 1,719 Amid Price Pressure
2025-10-16 19:28:11Sumitomo Pharma Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite a strong annual return, the company faces profitability challenges, highlighted by a low Return on Equity and a negative EBIT to Interest ratio, indicating difficulties in managing its debt.
Read More
Sumitomo Pharma Hits Day Low of JPY 1,707 Amid Price Pressure
2025-10-15 17:57:52Sumitomo Pharma Co., Ltd. saw a notable decline in its stock price, contrasting with the modest decrease of the Japan Nikkei 225. Despite recent challenges, the company has shown strong annual performance, with significant returns and solid financial metrics, including a notable operating cash flow and return on equity.
Read More
Sumitomo Pharma Hits Day High with 7.41% Surge in Stock Price
2025-10-01 17:13:00Sumitomo Pharma Co., Ltd. has shown strong stock performance, with a notable increase on September 30, 2025. The company reported significant financial metrics, including a substantial operating cash flow and impressive half-year net sales growth. Despite some long-term challenges, its current valuation remains appealing in the pharmaceuticals sector.
Read More





